Results 1 to 10 of about 3,880 (180)

FDFT1 maintains glioblastoma stem cells through activation of the Akt pathway [PDF]

open access: yesStem Cell Research and Therapy
Background Cancer stem cells (CSCs) have unique metabolic characteristics and are hypothesized to contribute significantly to the recurrence and drug resistance of glioblastoma multiforme (GBM).
Jianwei Liao
exaly   +5 more sources

Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis [PDF]

open access: yesAdvanced Science
Targeting cholesterol metabolism is a novel direction for tumor therapy. Unfortunately, the current use of statins for hepatocellular carcinoma (HCC) is controversial.
Dong Cai   +9 more
exaly   +5 more sources

Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC

open access: yesCancer Medicine, 2022
Renal cell carcinoma (RCC) seriously threatens people's lives and health. The identification of some precise biomarkers during the process of RCC progression and the pathophysiologic procedure is critical for improving the diagnosis and management of RCC.
Ruizhen Huang, Honglin Hu
exaly   +4 more sources

Schwann Cell Synthesized Cholesterol Orchestrates Peripheral Nerve Regeneration via Structural and IGF1‐Dependent Signaling Mechanisms [PDF]

open access: yesAdvanced Science
Peripheral nerve myelin is the most cholesterol‐rich structure in the body, with the majority of cholesterol being synthesized by Schwann Cells (SCs). Following peripheral nerve injury, myelin disintegration leads to substantial cholesterol release and ...
Shuyi Xu   +12 more
doaj   +3 more sources

FDFT1/FGFR2 rearrangement: A newly identified anlotinib-sensitive FGFR2 variant in cholangiocarcinoma

open access: yesCancer Treatment and Research Communications, 2022
According to previous reports,10–16% of patients with clinically advanced cholangiocarcinoma develop FGFR2 fusions or rearrangements. Treatment with FGFR2-specific inhibitors (tyrosine kinase inhibitors, TKIs) has proven effective for patients with ...
Xiaojun Xiang, Jianping Xiong, Jun Deng
exaly   +5 more sources

Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review [PDF]

open access: yesCellular and Molecular Biology Letters, 2022
Bladder cancer is the fourth most common malignancy in males. It can present across the whole continuum of severity, from mild through well-differentiated disease to extremely malignant tumours with poor survival rates.
Siti Fairus Abdul Sani   +2 more
exaly   +4 more sources

RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression [PDF]

open access: yesNature Communications, 2020
Evidence suggests that fasting exerts extensive antitumor effects in various cancers, including colorectal cancer (CRC). However, the mechanism behind this response is unclear.
Wan-kun Chen, Nan Jiang, Jin Zhang
exaly   +5 more sources

THEM6 modulates carboplatin sensitivity by regulating ferroptosis through FDFT1 in triple-negative breast cancer [PDF]

open access: yesBreast Cancer Research
Background Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis, as chemotherapy resistance leads to relapse in many patients. Carboplatin addition improves treatment response, but challenges persist.
Yuexiang Zeng   +8 more
doaj   +3 more sources

Follicle stimulating hormone stimulates farnesyl-diphosphate farnesyltransferase 1 expression through LSD1Ser54p in chicken ovarian granulosa cells [PDF]

open access: yesPoultry Science
Ovarian follicular development in laying hens is tightly regulated by a variety of endocrine and cellular factors, among which follicle-stimulating hormone (FSH) plays a decisive role.
Yanhong Zhang   +3 more
doaj   +2 more sources

Lycorine hydrochloride inhibits cholangiocarcinoma through cholesterol biosynthesis and PTPN11 nuclear translocation [PDF]

open access: yesCell Communication and Signaling
Background Intrahepatic Cholangiocarcinoma (ICC) is a highly aggressive malignancy with limited treatment options. Identifying novel therapeutic agents for ICC is crucial.
Fengyun Zhao   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy